Close Menu

NEW YORK (GenomeWeb) WIRB-Copernicus Group (WCG) today said that its Clinical Services Division has entered a strategic partnership with InformedDNA, under which the companies will create a new "Center for Genetics and Precision Medicine in Clinical Trials," offering support services to biopharmaceutical companies, contract research organizations, and academic institutions in the design and conduct of precision medicine clinical trials.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.